Cargando…
Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients
OBJECTIVES: The purpose of this study was to validate computed tomography measured ECV (ECV(CT)) as part of routine evaluation for the detection of cardiac amyloid in patients with aortic stenosis (AS)-amyloid. BACKGROUND: AS-amyloid affects 1 in 7 elderly patients referred for transcatheter aortic...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536272/ https://www.ncbi.nlm.nih.gov/pubmed/32771574 http://dx.doi.org/10.1016/j.jcmg.2020.05.029 |
Sumario: | OBJECTIVES: The purpose of this study was to validate computed tomography measured ECV (ECV(CT)) as part of routine evaluation for the detection of cardiac amyloid in patients with aortic stenosis (AS)-amyloid. BACKGROUND: AS-amyloid affects 1 in 7 elderly patients referred for transcatheter aortic valve replacement (TAVR). Bone scintigraphy with exclusion of a plasma cell dyscrasia can diagnose transthyretin-related cardiac amyloid noninvasively, for which novel treatments are emerging. Amyloid interstitial expansion increases the myocardial extracellular volume (ECV). METHODS: Patients with severe AS underwent bone scintigraphy (Perugini grade 0, negative; Perugini grades 1 to 3, increasingly positive) and routine TAVR evaluation CT imaging with ECV(CT) using 3- and 5-min post-contrast acquisitions. Twenty non-AS control patients also had ECV(CT) performed using the 5-min post-contrast acquisition. RESULTS: A total of 109 patients (43% male; mean age 86 ± 5 years) with severe AS and 20 control subjects were recruited. Sixteen (15%) had AS-amyloid on bone scintigraphy (grade 1, n = 5; grade 2, n = 11). ECV(CT) was 32 ± 3%, 34 ± 4%, and 43 ± 6% in Perugini grades 0, 1, and 2, respectively (p < 0.001 for trend) with control subjects lower than lone AS (28 ± 2%; p < 0.001). ECV(CT) accuracy for AS-amyloid detection versus lone AS was 0.87 (0.95 for (99m)Tc-3,3-diphosphono-1,2-propanodicarboxylic acid Perugini grade 2 only), outperforming conventional electrocardiogram and echocardiography parameters. One composite parameter, the voltage/mass ratio, had utility (similar AUC of 0.87 for any cardiac amyloid detection), although in one-third of patients, this could not be calculated due to bundle branch block or ventricular paced rhythm. CONCLUSIONS: ECV(CT) during routine CT TAVR evaluation can reliably detect AS-amyloid, and the measured ECV(CT) tracks the degree of infiltration. Another measure of interstitial expansion, the voltage/mass ratio, also performed well. |
---|